IDEAS home Printed from https://ideas.repec.org/d/hpucdus.html

Publications

by members of

University of California-Davis → School of Medecine → Department of Public Health Sciences → Division of Health Policy and Management

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Journal articles | Chapters |

Journal articles

2024

  1. Shuai Chen & Heejung Bang & Jeffrey S. Hoch, 2024, "A Tutorial on Net Benefit Regression for Real-World Cost-Effectiveness Analysis Using Censored Data from Randomized or Observational Studies," Medical Decision Making, , volume 44, issue 3, pages 239-251, April, DOI: 10.1177/0272989X241230071.
  2. Yanara Marks & Jeffrey S. Hoch & Anna Heath & Petros Pechlivanoglou, 2024, "Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results," PharmacoEconomics, Springer, volume 42, issue 7, pages 783-795, July, DOI: 10.1007/s40273-024-01374-y.

2019

  1. Sandjar Djalalov & Jaclyn Beca & Emmanuel M. Ewara & Jeffrey S. Hoch, 2019, "A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis," PharmacoEconomics, Springer, volume 37, issue 12, pages 1525-1536, December, DOI: 10.1007/s40273-019-00830-4.

2018

  1. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018, "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, volume 36, issue 1, pages 7-15, January, DOI: 10.1007/s40273-017-0583-4.
  2. Malek B. Hannouf & Eric Winquist & Salaheddin M. Mahmud & Muriel Brackstone & Sisira Sarma & George Rodrigues & Peter K. Rogan & Jeffrey S. Hoch & Gregory S. Zaric, 2018, "The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study," PharmacoEconomics - Open, Springer, volume 2, issue 3, pages 255-270, September, DOI: 10.1007/s41669-017-0051-2.
  3. David G. T. Whitehurst & Nicholas R. Latimer & Aura Kagan & Rebecca Palmer & Nina Simmons-Mackie & J. Charles Victor & Jeffrey S. Hoch, 2018, "Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom," PharmacoEconomics - Open, Springer, volume 2, issue 3, pages 225-231, September, DOI: 10.1007/s41669-018-0083-2.

2017

  1. S Lucas Goede & Linda Rabeneck & Marjolein van Ballegooijen & Ann G Zauber & Lawrence F Paszat & Jeffrey S Hoch & Jean H E Yong & Sonja Kroep & Jill Tinmouth & Iris Lansdorp-Vogelaar, 2017, "Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening," PLOS ONE, Public Library of Science, volume 12, issue 3, pages 1-15, March, DOI: 10.1371/journal.pone.0172864.
  2. Kavisha Jayasundara & Murray Krahn & Muhammad Mamdani & Jeffrey S. Hoch & Paul Grootendorst, 2017, "Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology," PharmacoEconomics - Open, Springer, volume 1, issue 3, pages 167-173, September, DOI: 10.1007/s41669-017-0022-7.
  3. Lisa Masucci & Jaclyn Beca & Mona Sabharwal & Jeffrey S. Hoch, 2017, "Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)," PharmacoEconomics - Open, Springer, volume 1, issue 4, pages 255-263, December, DOI: 10.1007/s41669-017-0018-3.

2016

  1. Carolyn S Dewa & Lucy Trojanowski & Sietske J Tamminga & Jolie Ringash & Maurene McQuestion & Jeffrey S Hoch, 2016, "Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors," PLOS ONE, Public Library of Science, volume 11, issue 4, pages 1-13, April, DOI: 10.1371/journal.pone.0152944.
  2. Amy Tawfik & Walter P. Wodchis & Petros Pechlivanoglou & Jeffrey Hoch & Don Husereau & Murray Krahn, 2016, "Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation," Applied Health Economics and Health Policy, Springer, volume 14, issue 3, pages 313-322, June, DOI: 10.1007/s40258-016-0229-2.

2015

  1. Wanrudee Isaranuwatchai & Maureen Markle-Reid & Jeffrey Hoch, 2015, "Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters," PharmacoEconomics, Springer, volume 33, issue 10, pages 1083-1090, October, DOI: 10.1007/s40273-015-0287-6.
  2. Jeffrey Hoch & Jaclyn Beca & Mona Sabharwal & Scott Livingstone & Anthony Fields, 2015, "Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?," PharmacoEconomics, Springer, volume 33, issue 8, pages 879-882, August, DOI: 10.1007/s40273-015-0278-7.

2014

  1. Regier, Dean A. & Bentley, Colene & Mitton, Craig & Bryan, Stirling & Burgess, Michael M. & Chesney, Ellen & Coldman, Andy & Gibson, Jennifer & Hoch, Jeffrey & Rahman, Syed & Sabharwal, Mona & Sawka, , 2014, "Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control," Social Science & Medicine, Elsevier, volume 122, issue C, pages 130-139, DOI: 10.1016/j.socscimed.2014.10.038.
  2. Sandjar Djalalov & Linda Rabeneck & George Tomlinson & Karen E. Bremner & Robert Hilsden & Jeffrey S. Hoch, 2014, "A Review and Meta-analysis of Colorectal Cancer Utilities," Medical Decision Making, , volume 34, issue 6, pages 809-818, August, DOI: 10.1177/0272989X14536779.

2013

  1. Jean Yong & Jaclyn Beca & Jeffrey Hoch, 2013, "The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada," PharmacoEconomics, Springer, volume 31, issue 3, pages 229-236, March, DOI: 10.1007/s40273-012-0022-5.

2008

  1. Hoch, Jeffrey S. & Blume, Jeffrey D., 2008, "Measuring and illustrating statistical evidence in a cost-effectiveness analysis," Journal of Health Economics, Elsevier, volume 27, issue 2, pages 476-495, March.

2007

  1. Jeffrey Hoch & Carolyn Dewa, 2007, "Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions," PharmacoEconomics, Springer, volume 25, issue 10, pages 807-816, October, DOI: 10.2165/00019053-200725100-00001.

2004

  1. Andrew R. Willan & Andrew H. Briggs & Jeffrey S. Hoch, 2004, "Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data," Health Economics, John Wiley & Sons, Ltd., volume 13, issue 5, pages 461-475, May, DOI: 10.1002/hec.843.

2002

  1. Jeffrey S. Hoch & Andrew H. Briggs & Andrew R. Willan, 2002, "Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., volume 11, issue 5, pages 415-430, July, DOI: 10.1002/hec.678.

Chapters

2021

  1. Carolyn S. Dewa & Jeffrey S. Hoch, 2021, "Labs and cases in health insurance and cost-effectiveness analyses to enhance active learning experiences in an introductory healtheconomics course for students in health professions," Chapters, Edward Elgar Publishing, chapter 4, in: Maia Platt & Allen C. Goodman, "Handbook on Teaching Health Economics".
  2. Jeffrey S. Hoch & Carolyn S. Dewa, 2021, "Using net benefit regression to teach cost-effectiveness analysis with a dataset," Chapters, Edward Elgar Publishing, chapter 6, in: Maia Platt & Allen C. Goodman, "Handbook on Teaching Health Economics".

2018

  1. Jeffrey S. Hoch & Pierre Chaussé, 2018, "Econometric Considerations When Using the Net Benefit Regression Framework to Conduct Cost-effectiveness Analysis," Contributions to Economic Analysis, Emerald Group Publishing Limited, "Health Econometrics", DOI: 10.1108/S0573-855520180000294007.

2013

  1. Jeffrey S. Hoch, 2013, "Improving the Efficiency of Cost-effectiveness Analysis to Inform Policy Decisions in the Real World: Lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario," International Series in Operations Research & Management Science, Springer, chapter 0, in: Gregory S. Zaric, "Operations Research and Health Care Policy", DOI: 10.1007/978-1-4614-6507-2_18.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.